Navigation Links
Baxa Corporation Signs Strategic Reseller Agreement With MedKeeper for Web-Based Productivity Tool
Date:11/21/2007

Baxa Corporation announces its agreement with MedKeeper to market and sell

a Web-based program that tracks pharmacy doses from order entry to

delivery.

ENGLEWOOD, Colo., Nov. 21 /PRNewswire/ -- Baxa Corporation has signed a strategic reseller agreement with MedKeeper to promote its Web-based pharmacy dose tracking software. Under the agreement, Baxa Corporation has exclusive sales and distribution rights for all worldwide healthcare markets for the MedKeeper software.

"We are excited about the opportunities that this agreement represents for improving pharmacy operations," stated Greg Baldwin, Baxa CEO. "The MedKeeper software complements Baxa syringe filling products and accessories, providing a means to track prepared doses to ensure that they reach their destination." The MedKeeper application provides pharmacy with the means to track the time it takes to prepare and approve drug doses, and subsequently follows them until they have been administered -- preventing losses and reducing the need for calls from nursing to track orders.

Denver-based MedKeeper specializes in software tools that support clinical pharmacy. According to company President Jason Kilgour, "Our products focus on streamlining pharmacy communications, eliminating unnecessary costs, ensuring regulatory compliance and enhancing pharmacy practice. Working together supports Baxa Corporation's strategic focus on providing productivity and compliance tools for pharmacy."

Baxa Corporation plans to launch the MedKeeper software tool at the American Society for Health-System Pharmacists (ASHP) Mid-Year Meeting in Las Vegas, December 2 - 5. The company's booth will focus on promoting its suite of productivity and compliance tools for improving pharmacy performance.

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. It
'/>"/>

SOURCE Baxa Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
7. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
8. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
9. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
10. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
11. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... , , FREMONT, Calif., Dec. 3 /PRNewswire...r Research (AACR) released findings today from one... and breast cancer in women conducted by the Nort...dy data revealed that women who never smoked cigar... smoke over a lifetime--especially during adulthoo...
(Date:12/3/2009)... , , Recent CBO analysis understates...INGTON, Dec. 3 A new ac...average annual medical claims in the new individua...oday five years after implementation of healthcare...e Care Act (PPACA), excluding the impact of medica...
(Date:12/3/2009)... , Harmful procedures on ...p test – HiFi DNA Tech sues FDA on December ... Trumbull, CN (PRWEB) December 2, 2009 -- ...ecologists has confirmed that the invasive cancer ...y, is harmful and may be unnecessary to some women...
(Date:12/3/2009)... , , MUNICH, Germany, PARSIPPANY, N.J. ...ns, the number one Enterprise Image Intelligence&#...lly owned subsidiary of Pro Medicus Ltd. (ASX: PME...rtnership to jointly develop and market advanced o... imaging domain. ,, The partnership enables Def...
(Date:12/3/2009)... , , CHAPEL HILL, N.C., Dec. 3 /PRNewsw... health workers, IntraHealth International has c...Pauline Wambui Muhuhu. President and CEO Pape Gaye... Award, with a small cash prize, during a ceremony...his week. ,, With the annual award, IntraHealt...
Breaking Medicine News(10 mins):Health News:Northern California Cancer Center's Findings on Breast Cancer and Secondhand Smoke Released Internationally by the American Association for Cancer Research 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4Health News:Harmful Procedures on Young Women Caused by Outdated HPV test, not by Pap Test 2Health News:Visage Imaging and Definiens Announce Partnership 2Health News:Visage Imaging and Definiens Announce Partnership 3Health News:Inaugural 'Health Worker Leadership Award' Honors Kenyan Midwife, IntraHealth Senior Leader 2
...prevent many women from getting pregnant, but visi...restore fertility, a US researcher concluded.// ...mined the value of psychological treatment for wom...6 women was small and that a larger investigation ...
...g in seven hospitals in the west and north-west b...table according to Fine Gael because resources for...ont-bench spokesman Denis Naughten said: “Public h...st and north-west, where hospitals had overspent t...
... claimed the lives of 271 people this year in Assa...here. // Replying to the debate on cut motio...l could be higher as information from interior are...rea has been covered. In the two most affecte...
... in charge of maintaining the water level in the b...reted out. When the kidneys get affected, it resul...might lead to health complications and even chroni...l failure is not easy to detect and there are no a...
...reater contribution to global health affairs, Chin... for the post of Director-General of World Health ...as WHO Assistant Director-General for Communicable... Korea in May this year. China's Foreign Mini...
... from the US have reported in a study, providing o...d cancer.// The researchers explained that i...lves to the tumor cells and act by stimulating new...ne also found that a blood pressure drug reverses ...
Other Medicine News:Health News:Stress Therapy can Restore Fertility: Study 2Health News:Overspending in Hospitals to Lead to Cutbacks 2Health News:Study Finds direct link Between stress And Ovarian Cancer 2
(Date:12/3/2009)... WALTHAM, Mass., Dec. 3 Decision...d advisory firms focusing on pharmaceutical and he...s drug market in Brazil will grow from $417 millio...5 percent annual growth rate is attributed to a gr...ased use of new generation antidiabetics such as M...
(Date:12/3/2009)...ELZE, Germany, Dec. 3 Honeywell (N...tion agreement with Pro-Lab Laboratuar Teknolojile...; Jackson® high-purity solvents in Turkey. ,...ively by biotechnology and pharmaceutical companie..., "The annual growth rate of the Turkish pharmac...
(Date:12/3/2009)...ERSUSALEM and NEEDHAM, Massachusetts, December 3 /... Swiss Exchange: ORIDN) today announced that the B...capnographs for its RTW (Rettungswagen) medical ve...teams to assess the ventilation status of a patien...iratory status such as displaced endotracheal tube...
Breaking Medicine Technology:Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 2Brazil's Type 2 Diabetes Drug Market Will Grow to $834 Million by 2013 3Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 2Honeywell and Pro-Lab Sign Distribution Agreement for Laboratory Chemicals in Turkey 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 2Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 3Oridion Microstream(R) Technology Chosen by the Bavarian Red Cross for Improved Patient Safety 4Gene Discovery Gives Clues to Crohns Disease Colitis 60715 1Gene Discovery Gives Clues to Crohns Disease Colitis 60715 2Gene Discovery Gives Clues to Crohns Disease Colitis 60715 3Nationally Known Psychotherapist Dr Robi Ludwig Joins Qualsecs Wholly Owned Subsidiary VitaminSpice 60711 1Nationally Known Psychotherapist Dr Robi Ludwig Joins Qualsecs Wholly Owned Subsidiary VitaminSpice 60711 2Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 1Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 2Regence Foundation Announces Largest Set of Quarterly Grant Awards in Its History 60707 3
..., May 29 GlaxoSmithKline [NYSE: GSK] and Genmab ...tes Food and Drug Administration,s (FDA) Oncologic... that the ARZERRA(TM) (ofatumumab) data are reason...ts with chronic lymphocytic leukemia (CLL) whose d...b. Ofatumumab is an investigational treatment. , ...
... Perceptive Informatics, the industry,s leading e...REXEL International Corporation (Nasdaq: PRXL ),...to help investigators apply the new 1.1 version of...ors) in medical imaging-based oncology trials. Per...n the RECIST Working Group, has incorporated into ...
Other Medicine Technology:FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 2FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 3FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 4FDA Advisory Panel Makes Favorable Recommendation for GlaxoSmithKline and Genmab's ARZERRA(TM) (ofatumumab) 5Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 2Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 3Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 4Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials 5
...Fill2 is the ideal system for fast, accurate filli...pinch valve controlled dispensing mechanism, ensur... of the components that come into contact with the...oclave. The unique compact design saves valuable b...
...Fill2 is the ideal system for fast, accurate filli...pinch valve controlled dispensing mechanism, ensur... of the components that come into contact with the...oclave. The unique compact design saves valuable b...
...Fill2 is the ideal system for fast, accurate filli...pinch valve controlled dispensing mechanism, ensur... of the components that come into contact with the...oclave. The unique compact design saves valuable b...
...atic dispenser for low volumes. Dispenses volumes ...throughput of less than 30 seconds per plate signi...ures an intuitive user interface that provides one...uids and suspensions, beads, or cells, with high p...
Medicine Products: